OAM
MNOV icon

Oxford Asset Management’s MediciNova MNOV Stock Holding History

Oxford Asset Management’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-44,734
Closed -$338K – 817
2016
Q2 		$338K Buy
+44,734
New +$324K 0.01% 641

Other funds holding MNOV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Oxford Asset Management's MNOV Position: Q3 2016 in Review

Oxford Asset Management sold out of MediciNova (MNOV) in Q3 2016, closing a stake of 44,734 shares — an estimated $338K sold.

Oxford Asset Management first reported a position in MNOV in Q2 2016 and held it in 1 quarter. The position peaked at $338K in Q2 2016. 51 funds tracked by Wall St. Rank hold MNOV as of Q3 2016.

  • Oxford Asset Management reported no remaining MediciNova position as of Q3 2016 after selling out during the quarter.
  • Oxford Asset Management sold 44,734 MediciNova shares in Q3 2016, an estimated $338K.
  • Oxford Asset Management first reported a position in MediciNova in Q2 2016 and held it in 1 quarter.
  • Oxford Asset Management's MediciNova position peaked at $338K in Q2 2016.
  • 51 funds tracked by Wall St. Rank held MediciNova as of Q3 2016.

Based on Oxford Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.